Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome (ISAR-REACT-4)

Clinical Trial ID NCT00373451

PubWeight™ 6.47^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00373451

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.	Eur Heart J	2005	6.86
2	ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).	J Am Coll Cardiol	2002	4.64
3	Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.	JAMA	2006	4.18
4	Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.	JAMA	2003	3.52
5	Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.	J Am Coll Cardiol	2012	1.49
6	One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial.	EuroIntervention	2013	1.47
7	Antiplatelet therapy in non-ST-segment elevation acute coronary syndromes.	JAMA	2004	1.45
8	Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction.	N Engl J Med	2011	1.20
9	Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.	Circ Cardiovasc Interv	2012	0.79
10	Sex-related effectiveness of bivalirudin versus abciximab and heparin in non-ST-segment elevation myocardial infarction.	Am Heart J	2013	0.76
11	The impact of smoking on the antiplatelet action of clopidogrel in non-ST-elevation myocardial infarction patients: results from the ISAR-REACT 4 platelet substudy.	J Thromb Haemost	2012	0.76